LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/ADA Opioid Allegations Cost New England Ortho Practice
Legal & Regulatory and Reimbursement

ADA Opioid Allegations Cost New England Ortho Practice

June 7, 2021 1 min read Premium comments

Advertisement

Secondary#americanswithdisabilityact#newenglandorthopedicsurgeons#opioidusedisorder

A Springfield, Massachusetts-based New England Orthopedic Surgeon (NEOS) practice was accused of discriminating against patients with Opioid Use Disorder (a category under the Americans with Disabilities Act) and have agreed to settle any allegations that the orthopedic practice violated the Americans with Disabilities Act.

NEOS is an 18-physician practice. Its physicians perform surgeries at Baystate Medical Center (Baystate) and are required to follow Baystate policies and procedures for those surgeries. In 2019, Baystate changed its protocols involving patients who were being prescribed buprenorphine treatment. The change required that those patients be maintained on the medication when undergoing total joint replacement.

In the settlement agreement, NEOS claims that it “had safety concerns about managing post-operative pain under Baystate’s protocol, and, therefore, for a five-month period, while it was consulting with professionals regarding Baystate’s new protocol, it did not perform total joint replacement surgeries on individuals who were prescribed buprenorphine.”

The U.S. “found that NEOS denied two individuals a total joint replacement surgery because they were prescribed Suboxone.” Suboxone is a medication containing both buprenorphine and naloxone.

Under the ADA, individuals with Opioid Use Disorder are individuals with a disability and are entitled to ADA protections. According to the settlement agreement, by refusing to operate on individuals taking medication for their Opioid Use Disorder, NEOS “imposed eligibility criteria that screened out individuals with disabilities on the basis of their disability in violation of the ADA.”

NEOS entered into the settlement agreement “to avoid further litigation of this matter.” In the settlement agreement, “NEOS expressly denies that it discriminated against complainant because she was prescribed buprenorphine.”

To resolve the matter, NEOS is taking certain actions in accordance with the settlement agreement including not discriminating against individuals on the basis of Opioid Use Disorder. Further, NEOS will draft, adopt, and enforce a nondiscrimination policy. NEOS will also provide training to employees and contractors on the ADA and Opioid Use Disorder. Finally, NEOS has agreed to pay $15,000 to each of the two individuals that were denied treatment.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy